EN
News Releases

News Releases

News Releases

Home>News Releases

Headlines

ce62d7c44efc836ae4ab2aaeef7fb14.jpg

NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC

NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC


  Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Notice of Drug Clinical Trial Approval from the ...

  Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Noti...

Detailed>>

Detailed +

2021.10

2021.10.09

NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC

NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC


  Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Noti...

2021.10

2021.10.08

A Delegation Led by Zhang Boli Visiting CR Sanjiu

A Delegation Led by Zhang Boli Visiting CR Sanjiu


  On October 7, a delegation led by Zhang Boli, an academician with the Chinese Academy of Engineering and recipient of the national h...

2021.09

2021.09.17

Remaining Committed to Charity - The CR Healthy Village Program Keeping up the Good Work

Remaining Committed to Charity - The CR Healthy Village Program Keeping...


  The meeting for wrapping up the CR Healthy Village Program with the theme of “Boosting Primary-Level Medical Services and Supportin...

2021.08

2021.08.04

CR Double-Crane’s Sodium Valproate Tablets Fluconazole and Sodium Chloride Injection Passing Consistency Evaluation of Generic Drugs

CR Double-Crane’s Sodium Valproate Tablets Fluconazole and Sodium Chlo...


  On August 4, CR Double-Crane issued an announcement that the Sodium Valproate Tablets produced by Hunan Xiangzhong Pharmaceutical Co...

2021.07

2021.07.21

2021.07

2021.07.20

CR Pharmaceutical proposed to acquire 10.0% stake in Immunotech Biopharm

CR Pharmaceutical proposed to acquire 10.0% stake in Immunotech Biopharm


  On 20 July, Beijing Pharmaceutical Investment and Management (BVI) Limited, a wholly-owned subsidiary of the Company and as a purcha...

2021.07

2021.07.12

CR Biopharmaceutical and Biocytogen reach a comprehensive strategic cooperation for the development of multiple target antibody drugs

CR Biopharmaceutical and Biocytogen reach a comprehensive strategic coo...


  On July 12, China Resources Biopharmaceutical Co., Ltd. (hereafter referred to as CR Biopharmaceutical) and Biocytogen Pharmaceutica...
Back to Top